{
    "2020-11-21": [
        [
            {
                "time": "",
                "original_text": "万泰生物变更1.5亿募集资金用途 首发近四分之三资金投向HPV疫苗",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "募集资金",
                        "用途变更",
                        "HPV疫苗"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}